Skip to content
Try Mental Wellness – Lifestyle
Author:
Expression Therapeutics
Expression Therapeutics CEO to Attend 45th J.P. Morgan Healthcare Conference 2027
November 11, 2026
Expression Therapeutics Awarded NCI SBIR Grant to Advance ET501, a PTK7-Targeted γδ T-Cell Therapy for Children with High-Risk Neuroblastoma
October 15, 2026